Cargando…
0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models
BACKGROUND: As a keratolytic, salicylic acid (SA) can be topically applied in various formulations and doses in dermatology. Supramolecular SA hydrogel, a new SA formulation with higher bioavailability, is developed and commercially available nowadays. However, there still remain concerns that the l...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228590/ https://www.ncbi.nlm.nih.gov/pubmed/37260764 http://dx.doi.org/10.2147/DDDT.S397541 |
_version_ | 1785050996664172544 |
---|---|
author | Zhou, Can Hua, Chunting Liang, Qichang Al Rudaisat, Mus’ab Chen, Siji Song, Yinjing Zhu, Jiang Cheng, Hao |
author_facet | Zhou, Can Hua, Chunting Liang, Qichang Al Rudaisat, Mus’ab Chen, Siji Song, Yinjing Zhu, Jiang Cheng, Hao |
author_sort | Zhou, Can |
collection | PubMed |
description | BACKGROUND: As a keratolytic, salicylic acid (SA) can be topically applied in various formulations and doses in dermatology. Supramolecular SA hydrogel, a new SA formulation with higher bioavailability, is developed and commercially available nowadays. However, there still remain concerns that the long-term and continual application of SA at low concentrations may jeopardize the cutaneous barrier properties. AIM OF THE STUDY: To reveal the long-term effects of 0.5–5% supramolecular SA hydrogel on the skin barrier in normal mice models. MATERIALS AND METHODS: The 0.5%, 1%, 2%, and 5% supramolecular SA hydrogel or hydrogel vehicle without SA was applied to mice’s shaved dorsal skin once per day respectively. Tissue samples of the dorsal skin were harvested on day 14 and 28 of the serial application of SA for histopathological observation and transcriptomic analysis. RESULTS: Following topical supramolecular SA hydrogel therapy with various concentrations of SA (0.5%, 1%, 2%, and 5%) for 14 days and 28 days, there were no obvious macroscopic signs of impaired cutaneous health and no inflammatory or degenerative abnormalities were observed in histological results. Additionally, the transcriptomic analysis revealed that on day 14, SA dramatically altered the expression of genes related to the extracellular matrix structural constituent. And on day 28, SA regulated gene expression profiles of keratinization, cornified envelope, and lipid metabolism remarkably. Furthermore, the expression of skin barrier related genes was significantly elevated after the application of SA based on RNA-seq results, and this is likely to be associated with the PPAR signaling pathway according to the enrichment analysis. CONCLUSION: Our findings demonstrated that the sustained topical administration of the 0.5–5% supramolecular SA hydrogel for up to 28 days did no harm to normal murine skin and upregulated the expression of genes related to the epidermal barrier. |
format | Online Article Text |
id | pubmed-10228590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102285902023-05-31 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models Zhou, Can Hua, Chunting Liang, Qichang Al Rudaisat, Mus’ab Chen, Siji Song, Yinjing Zhu, Jiang Cheng, Hao Drug Des Devel Ther Original Research BACKGROUND: As a keratolytic, salicylic acid (SA) can be topically applied in various formulations and doses in dermatology. Supramolecular SA hydrogel, a new SA formulation with higher bioavailability, is developed and commercially available nowadays. However, there still remain concerns that the long-term and continual application of SA at low concentrations may jeopardize the cutaneous barrier properties. AIM OF THE STUDY: To reveal the long-term effects of 0.5–5% supramolecular SA hydrogel on the skin barrier in normal mice models. MATERIALS AND METHODS: The 0.5%, 1%, 2%, and 5% supramolecular SA hydrogel or hydrogel vehicle without SA was applied to mice’s shaved dorsal skin once per day respectively. Tissue samples of the dorsal skin were harvested on day 14 and 28 of the serial application of SA for histopathological observation and transcriptomic analysis. RESULTS: Following topical supramolecular SA hydrogel therapy with various concentrations of SA (0.5%, 1%, 2%, and 5%) for 14 days and 28 days, there were no obvious macroscopic signs of impaired cutaneous health and no inflammatory or degenerative abnormalities were observed in histological results. Additionally, the transcriptomic analysis revealed that on day 14, SA dramatically altered the expression of genes related to the extracellular matrix structural constituent. And on day 28, SA regulated gene expression profiles of keratinization, cornified envelope, and lipid metabolism remarkably. Furthermore, the expression of skin barrier related genes was significantly elevated after the application of SA based on RNA-seq results, and this is likely to be associated with the PPAR signaling pathway according to the enrichment analysis. CONCLUSION: Our findings demonstrated that the sustained topical administration of the 0.5–5% supramolecular SA hydrogel for up to 28 days did no harm to normal murine skin and upregulated the expression of genes related to the epidermal barrier. Dove 2023-05-26 /pmc/articles/PMC10228590/ /pubmed/37260764 http://dx.doi.org/10.2147/DDDT.S397541 Text en © 2023 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Can Hua, Chunting Liang, Qichang Al Rudaisat, Mus’ab Chen, Siji Song, Yinjing Zhu, Jiang Cheng, Hao 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title | 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title_full | 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title_fullStr | 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title_full_unstemmed | 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title_short | 0.5–5% Supramolecular Salicylic Acid Hydrogel is Safe for Long-Term Topical Application and Improves the Expression of Genes Related to Skin Barrier Homeostasis in Mice Models |
title_sort | 0.5–5% supramolecular salicylic acid hydrogel is safe for long-term topical application and improves the expression of genes related to skin barrier homeostasis in mice models |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228590/ https://www.ncbi.nlm.nih.gov/pubmed/37260764 http://dx.doi.org/10.2147/DDDT.S397541 |
work_keys_str_mv | AT zhoucan 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT huachunting 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT liangqichang 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT alrudaisatmusab 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT chensiji 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT songyinjing 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT zhujiang 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels AT chenghao 055supramolecularsalicylicacidhydrogelissafeforlongtermtopicalapplicationandimprovestheexpressionofgenesrelatedtoskinbarrierhomeostasisinmicemodels |